Employee Stories > Article details

Be confident, persevering and do not drift away from your motivation, and gain stronger sense of calling and accomplishment

2022.05.13 | Boan Biotech,Shandong Boan Biotech, Boan Innovative Antibodies,Boan Biosimilar

Q: Why did you choose Boan?


My decision was based on several reasons:

First, China has been giving strong support to the biopharmaceutical industry with a whole package of policies and mechanisms since then. China’s industries have been upgraded and transformed as it grows stronger. As a result, industries with solid technology backgrounds such as genetic recombination and antibody drug are bound to experience rapid growth.

Second, Biopharmaceutics based on genetic recombination technology in China has started rather late and thus has vast room for growth. There are many unmet needs in the market for medication (including the development of innovative drugs and market accessibility). In addition, thanks to its opening up and reform policy, China has been on the path of rapid development, which guarantees the foundation for the development of biopharmaceutics (this includes material foundation such as well-developed providers of equipment, raw and auxiliary material, and supplies, as well as talents and knowledge from experienced consulting firms and professional advisors). All of these made the industry started its rapid development.

Third, Luye Pharma Group is an international pharmaceutical company that committed to drug development (Boan is a subsidiary of Luye Pharma Group). Developing biologic drugs requires both strong R&D capabilities and the ability to promote them in the international market, both of which Luye Pharma has been renowned for in the Chinese market. I was deeply touched by its determination and vision. During my interview, I visited Luye Pharma and was impressed by its science-based rigorous approach, profound experience and knowledge as well as a team with people of diversified perspectives working closely together. I thought this could be an opportunity for me to use my experience and knowledge. What’s more, I am more accustomed to the culture and lifestyle in China.
 
Q: What do you think of Boan after becoming a part of it?

I definitely understand Boan a lot more. The company keeps increasing investment and have multiple innovative technology platforms. It has a diversified pipeline and adequate project management capabilities. Many investments and supports have also been provided for GMP factory and facilities. At Boan, everyone is good at learning and self-improvement. We have a young and energetic workforce that is positive about what they do and has a strong passion for learning. Employees are constantly learning and creating new things. Whenever they encountered problems, they would cooperate and discuss them, during which they can gain more progress together. What comes along with the progress of projects is the vastly improved competencies of staff from all departments. They have come a long way in terms of professional skills and project management capabilities.
 
Q: Which part of your job is most fulfilling in Boan?

Just like all the other professionals working in the pharmaceutical industry, there is nothing that would please me more than to see the project I have dedicated to for nearly a decade gain the approval from regulators, market recognition and benefit the patients. I am lucky to join Boan and witness together the whole process of bringing Boyounuo®, our very first commercialized product, to the market. We are also preparing to roll out our second product to the market this year. In addition, as a manager, I think the other equally important achievement is that our employees have greatly improved their capabilities both as individuals and as team players. In the Biotechnology Engineering Center where I am the director, our staff have enhanced their competencies considerably and learned so much from their work. In this department, we mainly engaged in pilot-scale production at the beginning, now we can produce all samples required for the application before the clinical trial and the ones used for Phase I/II/III trials. As such, we have realized the commercialization of GMP factories and the production capabilities required for marketed products.
 
Q: How do you think of Boan’s future development?

Boan has a very solid foundation and bright prospects. In the first phase, we developed biosimilars and gained abundant experience in CMC development. With the launch of the first product, Boyounuo®, the company began to transform from a Biotech company to an all-round BioPharma company. Meanwhile, the company has also reached certain milestones in terms of international effort, including the international multicenter trial conducted and the quality verification passed in Europe and the US. As to the technology roadmap, the company has made strategic investment in some popular issues. We have 

Contact us

No.39 Keji Avenue High-Tech Industrial Development Zone Yantai, Shandong Province, China

(86)0535-4379111

Follow me